Patent · US Active

Compositions and methods for identifying agents that alter expression of survivin

US7569221B2 · kind B2 · utility

2Cited by
0References
6Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 12, 2007
Grant dateAug 4, 2009
Priority date
Expiry dateNov 12, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/142
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided are compositions and methods for identifying agents that can modulate expression of the human survivin gene. The compositions include eukaryotic cells that contain a human survivin promoter sequence operably linked to a reporter gene. The method comprises determining whether a test agent can modulate transcription from a human survivin promoter sequence by adding a test agent to eukaryotic containing a human survivin promoter sequence operably linked to a reporter gene, measuring expression of the reporter gene and comparing expression of the reporter gene from to a control, wherein an increase or decrease of expression of the reporter gene relative to the control is indicative that the test agent can modulate transcription from a human survivin promoter. The method also comprises the use of SPlucTg mice for preclinical drug identification, including testing of candidate drug toxicity and efficacy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.